| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.0067 | 1 |